Loading...
Search for:
argus-ii
0.008 seconds
The argus-II retinal prosthesis implantation; from the global to local successful experience
, Article Frontiers in Neuroscience ; Volume 12, Issue SEP , 2018 ; 16624548 (ISSN) ; Afarid, M ; Attarzadeh, A ; Johari, M. K ; Mehryar, M ; Nowroozzadeh, M. H ; Rahat, F ; Peyvandi, H ; Farvardin, R ; Nami, M ; Sharif University of Technology
Abstract
Over the past few years, visual prostheses (namely, Argus II retinal implant) and gene therapy have obtained FDA approval in treating blindness resulting from retinitis pigmentosa. Compared to gene therapy; Argus II is less costly with a demonstrated favorable outcome, though the vision is yet artificial. To obtain better results, expectation counseling and preoperative retinal assessment are critical. The global experience with Argus II has enrolled no more than 300 cases so far. The first Argus II retinal prosthesis in Iran was successfully implanted in Shiraz (October 2017). To date, Argus II artificial retina is implanted in four patients in Iran. Beside successful surgery and...